Aer Therapeutics Closes $36 Million Series A Funding Round to Advance Development of an Innovative Mucolytic for the Treatment of Lung Diseases
Aer Therapeutics, a joint University College Dublin and University of California, San Francisco biopharmaceutical spin-out company developing novel in....
Source: alphagalileo.org